Diet soda alters brain connections, study suggests
NCT ID NCT07183254
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how long-term use of non-nutritive artificial sweeteners (like those in diet drinks) affects brain connectivity. Researchers will use resting-state MRI scans to compare brain activity in 100 healthy young adults who consume either low or high amounts of these sweeteners. The goal is to understand if these sweeteners change the brain's reward circuits, which could influence eating behavior.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how artificial sweeteners change brain activity, possibly guiding future research on diet and brain health.
- What could go wrong
- This is an observational study, not a treatment trial. It is small and early-stage, so results may not apply broadly or lead to direct health advice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 30 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men and women aged 18 to 30 (and in good health) * Having low or no sweetener consumption (\~8 mg ± 5.05 mg/day) or high consumption (\~80 mg ± 91.72 mg/day) * Having a BMI of 18.5 \< 24.9 * For young women: having effective contraception maintained throughout the study * Able to give informed consent to participate in the research * Affiliation to a Social Security scheme Exclusion Criteria: * Refusing to participate in the research * With impaired understanding, according to the investigator * Volunteer under guardianship/curatorship/deprived of liberty or under legal protection * Incompatibility of healthy volunteers with the medical imaging center's safety criteria for conducting 3 Tesla MRI experiments * Presenting "contraindications" to an MRI examination without injection: presence of metal parts in the body (electronic devices such as a pacemaker, a neurostimulator, cochlear implant, prostheses, intraocular foreign bodies, etc.), claustrophobia, obesity * Refusal to be informed in the event of an incidental discovery of an abnormality on MRI * Volunteer with neurological disease, psychiatric or behavioral disorders\* * Volunteer with addiction\*: * Nicotine: smoker or former smoker of less than 12 months; * Alcoholism - "AUDIT" test: Female score ≥ 6 and male score ≥ 7; * Drugs - "DAST-10": Score ≥ 1; * Gambling - "ICJE": Score ≥ 3 * Video games - Modified DSM IV Video Game Addiction Test: More than 4 positive responses. - Positive urine drug screen * Volunteer with an eating disorder (ED)\*: o Eating disorder - "SCOFF": At least two positive responses. - Volunteers with at least one chronic condition (obesity, diabetes, cardiovascular, renal, or hepatic diseases, etc.)\* * Pregnant or breastfeeding women, or healthy subjects wishing to conceive during the current study year\* * Any illness, health condition, or history deemed incompatible with the trial by the investigator * Volunteers following a specific or highly restrictive diet (vegetarians, vegans, or vegans; multiple dietary exclusions related to religion, food allergies or intolerances; diets related to intensive exercise or weight-loss)\* * Currently excluded from another study * Currently participating in another clinical trial, or in the exclusion period, or having received a total compensation amount exceeding €6,000 in the 12 months preceding the start of the trial, * This study is part of a larger research project, also involving cognitive tasks and the measurement of food preferences. These exclusion criteria were therefore added in order to standardize the profile of the participants.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy volunteers - male and female are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU Clermont-Ferrand
Clermont-Ferrand, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can paying attention to your body rewire your brain waves in 30 minutes?
- New lung imaging technique uses inhaled gas to see inside your lungs
- Quinoa cookie trial: a tasty way to fight obesity?
- New RNA drug ORN252 tested in humans for first time
- Scientists test drug binding in healthy lungs to guide future treatments
- New drug QLS7305 tested in healthy volunteers – first step for future therapies